Prosecution Insights
Last updated: April 19, 2026

Spark Therapeutics Inc.

10 pending office actions

Portfolio Summary

10
Total Pending OAs
5
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18262959 Compositions and Methods for Treating Hereditary Angioedema TINSLEY, BRENDAN THOMAS 1634 Non-Final OA Jul 26, 2023
17759183 COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS MATALKAH, FATIMAH KHALAF 1638 Non-Final OA Jul 20, 2022
17862622 COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS ABBOTT, KODYE LEE 1634 Final Rejection Jul 12, 2022
17309261 IN VITRO ASSAY FOR DETECTING ENHANCERS AND INHIBITORS OF ADENO ASSOCIATED VIRUS (AAV) VECTOR TRANSDUCTION AND/OR DETECTING OR QUANTITATING ANTI-AAV BINDING ANTIBODIES BATES, KEENAN ALEXANDER 1631 Final Rejection May 12, 2021
17052097 PLASMID FREE AAV VECTOR PRODUCING CELL LINES SALVOZA, M FRANCO G 1672 Non-Final OA Oct 30, 2020
16631692 APHERESIS METHODS AND USES GILL, RACHEL B 1671 Non-Final OA Jan 16, 2020
16627227 AAV VECTOR COLUMN PURIFICATION METHODS TSAY, MARSHA M 1656 Non-Final OA Dec 27, 2019
16319216 SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTORS PRODUCED THEREBY JADHAO, SAMADHAN JAISING 1672 Final Rejection Jan 18, 2019
16088693 CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION NICOL, ALEXANDER W 1634 Final Rejection Sep 26, 2018
15780542 SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR CLINICAL USE GRABER, JAMES J 1631 Final Rejection May 31, 2018

Managing Spark Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month